Table 1. Patients Receiving Treatment Intensification in the Triple Pill and Usual Care Groups.
| Treatment characteristic | No./total No. (%) | P value | |
|---|---|---|---|
| Triple pill | Usual care | ||
| Randomization visit | |||
| Not at BP target at visit | 348/349 (100)a | 351/351 (100) | >.99 |
| Treatment inertiab | 6/348 (1.7) | 96/351 (27.4) | <.001 |
| Week 6 visit | |||
| Not at BP target at visit | 106/329 (32.2) | 194/344 (56.4) | <.001 |
| Treatment inertiab | 92/106 (86.8) | 124/194 (63.9) | <.001 |
| Week 12 visit | |||
| Not reaching BP target | 90/329 (27.4) | 179/340 (52.6) | <.001 |
| Treatment inertiab | 81/90 (90) | 116/179 (64.8) | <.001 |
| Month 6 visit | |||
| Not reaching BP target | 97/318 (30.5) | 147/329 (44.7) | <.001 |
Abbreviation: BP, blood pressure.
a
One patient who reached target was still included in the study.
b
Denominator is the number of patients not reaching the BP target at the visit and excludes dropouts.